Fresenius Medical Care AG & Co. KGAA (ETR:FME) has been assigned a €95.60 ($113.81) price target by equities research analysts at Berenberg Bank in a note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price target points to a potential upside of 11.09% from the company’s previous close.

Other analysts also recently issued reports about the stock. Deutsche Bank set a €84.00 ($100.00) price target on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a “neutral” rating in a research report on Tuesday, August 8th. Citigroup set a €92.00 ($109.52) price target on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Tuesday, August 8th. Goldman Sachs Group set a €97.00 ($115.48) price target on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Tuesday, August 8th. J P Morgan Chase & Co set a €95.60 ($113.81) price target on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Tuesday. Finally, Independent Research set a €88.00 ($104.76) price target on shares of Fresenius Medical Care AG & Co. KGAA and gave the company a “neutral” rating in a research report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of €89.06 ($106.03).

Shares of Fresenius Medical Care AG & Co. KGAA (FME) traded down €0.04 ($0.05) during trading hours on Wednesday, hitting €86.06 ($102.45). 272,790 shares of the company were exchanged, compared to its average volume of 517,453. Fresenius Medical Care AG & Co. KGAA has a 1-year low of €71.49 ($85.11) and a 1-year high of €89.22 ($106.21).

TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/12/06/fresenius-medical-care-ag-95-60-price-target-at-berenberg-bank.html.

Fresenius Medical Care AG & Co. KGAA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with MarketBeat.com's FREE daily email newsletter.